SCHEMBL23747878

SCHEMBL23747878

CCCCC1(C)OC(=O)c2ccc(OC)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
MALT1 Q9UDY8 2/20 0.39
CYP1A1 P04798 1/20 0.38
TDP1 Q9NUW8 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
AVPR1A P37288 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
GAA P10253 1/20 0.37
IDO1 P14902 2/20 0.37
NQO1 P15559 1/20 0.37
POR P16435 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22609174 0.83 PTPN1 (0.48) CYP2C9CYP2C19NPSR1CYP1A1AVPR1A
SCHEMBL25440539 0.82 PPARG (0.40) CYP2C9CYP2C19NPSR1CYP1A1TDP1
SCHEMBL6101688 0.76 PGR (0.46) MALT1AVPR1AMEN1KMT2AGAA
SCHEMBL31115081 0.72 OPRM1 (0.36) CYP2C9CYP2C19NPSR1MALT1TDP1
SCHEMBL11109733 0.68 APEX1 (0.42) CYP2C19MEN1KMT2AGAA
SCHEMBL11826749 0.68 PDK2 (0.47) AVPR1AMEN1KMT2AGAAIDO1
SCHEMBL21553806 0.68 SMN1; SMN2 (0.45) MALT1NQO1PORCA1CA2
SCHEMBL3618729 0.67 EDNRA (0.52) NPSR1AVPR1AMEN1KMT2AGAA
SCHEMBL4725746 0.67 TP53 (0.48) CYP2C9CYP2C19NPSR1L3MBTL1AVPR1A
SCHEMBL10264703 0.66 CYP3A4 (0.75) CYP2C9CYP2C19NPSR1TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11434217-B2 Method for synthesis of lobaric acid and analog thereof KOREA INSTITUTE OF OCEAN SCIENCE AND TECHNOLOGY (KR) 2022-09-06 US disclosed
US-20210246112-A1 METHOD FOR SYNTHESIS OF LOBARIC ACID AND ANALOG THEREOF KOREA INSTITUTE OF OCEAN SCIENCE AND TECHNOLOGY (KR) 2021-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210246112-A1 METHOD FOR SYNTHESIS OF LOBARIC ACID AND ANALOG THEREOF PPP6C, PPP4C, PPP3CB CYP2C9 1800/4885CYP2C19 1368/4885NPSR1 4003/4885
US-11434217-B2 Method for synthesis of lobaric acid and analog thereof PPP6C, PPP4C, PPP3CB CYP2C9 1800/4885CYP2C19 1368/4885NPSR1 4003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.